Home Applications 207873 Application 207873
Type ANDA
Sponsor TEVA PHARMS USA Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 MESALAMINE MESALAMINE CAPSULE, DELAYED RELEASE;ORAL 400MG No No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 44 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A207873-001 MESALAMINE MESALAMINE 400MG CAPSULE, DELAYED RELEASE / ORAL RS 2019-05-09
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 2 of 2 · 44 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2022-10-28 04:53 UTC 2022-10 A207873-001 MESALAMINE 400MG CAPSULE, DELAYED RELEASE / ORAL AB 2019-05-09 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 A207873-001 MESALAMINE 400MG CAPSULE, DELAYED RELEASE / ORAL AB 2019-05-09 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 A207873-001 MESALAMINE 400MG CAPSULE, DELAYED RELEASE / ORAL AB 2019-05-09 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A207873-001 MESALAMINE 400MG CAPSULE, DELAYED RELEASE / ORAL RS 2019-05-09 a50c72e98297…
Observed Orange Book normalized TE history# openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 13 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 0093-5907 Mesalamine Mesalamine Teva Pharmaceuticals USA, Inc. ANDA Current 0093-5907 Mesalamine Mesalamine Teva Pharmaceuticals USA, Inc. ANDA Current 0093-5907 Mesalamine Mesalamine Teva Pharmaceuticals USA, Inc. ANDA Current 0093-5907 Mesalamine Mesalamine Teva Pharmaceuticals USA, Inc. ANDA Current 0093-5907 Mesalamine Mesalamine Teva Pharmaceuticals USA, Inc. ANDA Current 0093-5907 Mesalamine Mesalamine Teva Pharmaceuticals USA, Inc. ANDA Current 0093-5907 Mesalamine Mesalamine Teva Pharmaceuticals USA, Inc. ANDA Current 42291-563 Mesalamine Mesalamine AvKARE, Inc ANDA Current 42291-563 Mesalamine Mesalamine AvKARE ANDA Current 42291-563 Mesalamine Mesalamine AvKARE ANDA Current 60687-556 Mesalamine Mesalamine American Health Packaging ANDA Current 60687-556 Mesalamine Mesalamine American Health Packaging ANDA Current 60687-556 Mesalamine Mesalamine American Health Packaging ANDA Current
Documents# Document, Submission type, Date table Document Submission type Date 59081 ORIG 2019-06-17